Logo

    3d bioprinting

    Explore "3d bioprinting" with insightful episodes like "#79 “Tumore aus dem 3D Drucker!” mit Judith Hagenbuchner & Michael Ausserlechner, Leiter des ersten 3D Biodruck Labor", "3D Bioprinting | Accelerating Drug Discovery with Andrew Ridley, Ph.D." and "Episode 3: 3D-printed implant designed to repair spinal injuries" from podcasts like ""Digital Sensemaker | Der Podcast für Digitalisierung & Zukunft", "New Matter: Inside the Minds of SLAS Scientists" and "MRS Bulletin Materials News Podcast"" and more!

    Episodes (3)

    #79 “Tumore aus dem 3D Drucker!” mit Judith Hagenbuchner & Michael Ausserlechner, Leiter des ersten 3D Biodruck Labor

    #79 “Tumore aus dem 3D Drucker!” mit Judith Hagenbuchner & Michael Ausserlechner, Leiter des ersten 3D Biodruck Labor
    3D Drucker drucken mittlerweile auch Zellen und Tumore auf einem Chip! Versuchstiere werden arbeitslos durch die Digitalisierung, denn der Vorteil von 3D gedruckten Zellen ist: sie sind dreidimensional, tierversuchsfrei und reproduzierbar! Im 3D Bioprinting Labor in Innsbruck ist das möglich, mit meinen beiden Gästen spreche ich heute darüber genauer. Dipl.Ing.Dr. Judith Hagenbuchner und Dr. Michael J. Ausserlechner sind seit 2017 beide Leiter des ersten 3D-Bioprinting-Labor in Österreich. Michael ist Assistenz Professor an der Universitätsklinik für Kinderheilkunde I und Leiter des Forschungslabors für Molekularbiologie an der Kinderklinik. Judith ist wissenschaftliche Mitarbeiterin an der Abteilung für Kinderheilkunde II der Medizinischen Universität Innsbruck. Mehr zum 3D Bioprinting Labor: https://www.i-med.ac.at/bioprinting/index.html.de

    3D Bioprinting | Accelerating Drug Discovery with Andrew Ridley, Ph.D.

    3D Bioprinting | Accelerating Drug Discovery with Andrew Ridley, Ph.D.

    Andrew Ridley, Ph.D., joins Hannah to discuss Cellink's achievement in winning the New Product Award at SLAS Europe 2022. Ridley explains what 3D bioprinting is and how BIO CELLX, the innovative biodispenser from Cellink, is shaping the future of drug discovery and tissue engineering. Also, Ridley shares a glimpse into what Cellink has in store for future products and how Cellink can provide to anyone wanting to use their technology without any tissue engineering experience. 

    To learn more about Cellink, visit: https://www.cellink.com/

    About Andrew Ridley, Ph.D.:
    Ridley is an experienced Product Manager/Sales Director with a Ph.D. focused in Molecular and Cellular Biology and has a history of working in the biotechnology industry. Skilled in molecular/cell biology with a focus on cutting-edge technologies including microfluidics and 3D bioprinting.

    Stay connected with SLAS:

    About SLAS:
    SLAS (Society for Laboratory Automation and Screening) is an international professional society of academic, industry and government life sciences researchers and the developers and providers of laboratory automation technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.  For more information about SLAS, visit www.slas.org.

    SLAS publishes two peer-reviewed and MEDLINE-indexed scientific journals, SLAS Discovery and SLAS Technology. For more information about SLAS and its journals, visit www.slas.org/publications.

    Upcoming SLAS Events:
    SLAS 2022 Americas Sample Management Symposium

    • September 15-16, 2022
    • La Jolla, CA, USA

    SLAS 2022 AI Data Pipelines for Life Sciences Symposium

    • September 26-27, 2022
    • Seattle, WA, USA

    SLAS 2022 Bio Entrepreneurship Symposium

    • 27-28 October 2022
    • Brussels, Belgium

    Upcoming SLAS Events:

    SLAS Building Biology in 3D Symposium

    • April 16-17, 2024
    • Jupiter, FL, USA

    SLAS Europe 2024 Conference and Exhibition

    • May 27-29, 2024
    • Barcelona, Spain

    View the full events calendar

    Episode 3: 3D-printed implant designed to repair spinal injuries

    Episode 3: 3D-printed implant designed to repair spinal injuries

    A silicon chip with 4 million microscopic mirrors is used to shine UV light in a 3D pattern based on a digital MRI image of the spinal cord wound in rats. The light falls onto a mixture of poly(ethylene) glycol and gelatin methacrylate, which solidifies into the shape of the wound.

    Transcript
    PRACHI PATEL: Welcome to MRS Bulletin’s Materials News Podcast, providing breakthrough news & interviews with researchers on the hot topics of 3D bioprinting, artificial intelligence and machine learning, bioelectronics, perovskites, quantum materials, robotics, and synthetic biology. My name is Prachi Patel.

    Over 250,000 people around the world suffer a spinal cord injury every year. 

    SHAOCHEN CHEN: Spinal cord damage turns out to be a very devastating disease. You know people cannot walk, they feel nothing below the hip and other parts of the body. 

    PATEL: Shaochen Chen, a nanoengineer at the University of California in San Diego, worked with neuroscientists to 3D-print implants that can repair spinal cord injuries in rats. The implants are customized to fit the injury. The printer uses a silicon chip with four million microscopic mirrors to shine UV light in a three-dimensional pattern based on a digital MRI image of the wound. The light falls onto a mixture of poly(ethylene) glycol and gelatin methacrylate, which solidifies into the shape of the wound. The method is thousands of times faster than conventional 3D-printing techniques, which makes structures one drop or one layer at a time.

    CHEN: So you can imagine we have about 4 million of these traditional printers doing the same work. And the speed is totally different. We can print the similar sized part in a matter of seconds versus 3 or 4 or 6 hours.

    PATEL: Chen says the material and the structure of the implant make it unique. Neurons will usually grow around or turn away from foreign materials. But the hydrogel-gelatin combination attracts the cells. The implants have a solid supportive center surrounded by microchannels that are 200 micrometers in diameter. The researchers fill these channels with neural stem cells that urge neurons to grow.

    CHEN: So if you put this implant in the gap of the damaged site of the spinal cord you hope, you know, that neurons can grow from both ends, they’d reconnect with the help of this kind of implant just like a bridge.

    PATEL: That’s indeed what happened in rats with spinal cord injuries. The animals had no feeling or movement in their legs, but 11 weeks after getting the implants, they could feel their toes and move their knees. When the researchers removed the implants they saw that neurons had grown through the channels. The team is now moving on to test on monkeys. And Chen is doing a lot more with the 3D-printing method. 

    CHEN: We have been using this technique to print heart tissues, liver tissues, and brain tissue, and also cancer tissue models.

    PATEL: Pharmaceutical companies could use those printed human tissues for drug testing, which could drastically cut the time and cost of drug development.

    CHEN: They don’t need to wait until, you know, 10 years to see if this compound or this drug is toxic to the heart or liver in a human setting. And, of course, the long-term goal is to have therapeutical uses of this 3D-printed tissue because they can repair, regenerate damaged tissue, for instance heart wall, for instance piece of liver due to cancer you can cut it out and put this 3D-printed liver piece to fix it.

    PATEL: The research was published recently in the journal Nature Medicine. My name is Prachi Patel from the Materials Research Society.

    For more news, log onto the MRS Bulletin website at mrsbulletin.org and follow us on twitter, @MRSBulletin.